Medtronic PE Ratio 2012-2025 | MDT
Current and historical p/e ratio for Medtronic (MDT) from 2012 to 2025. The price to earnings ratio is calculated by taking the latest closing price and dividing it by the most recent earnings per share (EPS) number. The PE ratio is a simple way to assess whether a stock is over or under valued and is the most widely used valuation measure. Medtronic PE ratio as of January 14, 2026 is 17.13.
| Medtronic PE Ratio Historical Data | |||
|---|---|---|---|
| Date | Stock Price | TTM Net EPS | PE Ratio |
| 2026-01-14 | 98.74 | 26.61 | |
| 2025-10-31 | 90.04 | $3.71 | 24.27 |
| 2025-07-31 | 88.91 | $3.63 | 24.49 |
| 2025-04-30 | 82.82 | $3.62 | 22.88 |
| 2025-01-31 | 88.04 | $3.29 | 26.76 |
| 2024-10-31 | 85.78 | $3.27 | 26.23 |
| 2024-07-31 | 76.59 | $2.96 | 25.88 |
| 2024-04-30 | 75.84 | $2.75 | 27.58 |
| 2024-01-31 | 82.06 | $3.14 | 26.13 |
| 2023-10-31 | 65.59 | $3.07 | 21.37 |
| 2023-07-31 | 80.89 | $2.71 | 29.85 |
| 2023-04-30 | 83.18 | $2.82 | 29.50 |
| 2023-01-31 | 75.89 | $3.04 | 24.96 |
| 2022-10-31 | 78.50 | $3.22 | 24.38 |
| 2022-07-31 | 82.50 | $3.87 | 21.32 |
| 2022-04-30 | 92.34 | $3.73 | 24.76 |
| 2022-01-31 | 91.03 | $3.63 | 25.08 |
| 2021-10-31 | 104.76 | $3.47 | 30.19 |
| 2021-07-31 | 114.21 | $2.86 | 39.93 |
| 2021-04-30 | 113.30 | $2.66 | 42.59 |
| 2021-01-31 | 95.86 | $2.14 | 44.80 |
| 2020-10-31 | 86.17 | $2.62 | 32.89 |
| 2020-07-31 | 82.20 | $3.27 | 25.14 |
| 2020-04-30 | 82.63 | $3.55 | 23.28 |
| 2020-01-31 | 97.10 | $3.94 | 24.65 |
| 2019-10-31 | 91.17 | $3.46 | 26.35 |
| 2019-07-31 | 84.91 | $3.27 | 25.97 |
| 2019-04-30 | 73.57 | $3.42 | 21.51 |
| 2019-01-31 | 72.82 | $3.62 | 20.12 |
| 2018-10-31 | 73.58 | $1.65 | 44.60 |
| 2018-07-31 | 73.55 | $2.31 | 31.84 |
| 2018-04-30 | 64.93 | $2.26 | 28.73 |
| 2018-01-31 | 69.20 | $2.03 | 34.09 |
| 2017-10-31 | 64.51 | $3.65 | 17.67 |
| 2017-07-31 | 66.88 | $2.97 | 22.52 |
| 2017-04-30 | 65.83 | $2.89 | 22.78 |
| 2017-01-31 | 59.91 | $2.83 | 21.17 |
| 2016-10-31 | 64.26 | $3.01 | 21.35 |
| 2016-07-31 | 68.31 | $2.57 | 26.58 |
| 2016-04-30 | 61.40 | $2.48 | 24.76 |
| 2016-01-31 | 58.59 | $1.70 | 34.47 |
| 2015-10-31 | 56.77 | $1.91 | 29.72 |
| 2015-07-31 | 59.87 | $2.38 | 25.16 |
| 2015-04-30 | 56.58 | $2.68 | 21.11 |
| 2015-01-31 | 54.05 | $3.12 | 17.32 |
| 2014-10-31 | 51.38 | $2.89 | 17.78 |
| 2014-07-31 | 46.31 | $2.95 | 15.70 |
| 2014-04-30 | 43.91 | $3.01 | 14.59 |
| 2014-01-31 | 42.03 | $3.52 | 11.94 |
| 2013-10-31 | 42.45 | $3.74 | 11.35 |
| 2013-07-31 | 40.64 | $3.48 | 11.68 |
| 2013-04-30 | 34.15 | $3.38 | 10.10 |
| 2013-01-31 | 33.91 | $3.37 | 10.06 |
| 2012-10-31 | 30.07 | $3.28 | 9.17 |
| 2012-07-31 | 28.34 | $3.47 | 8.17 |
| 2012-04-30 | 27.28 | $3.41 | 8.00 |
| 2012-01-31 | 27.38 | $3.19 | 8.58 |
| 2011-10-31 | 24.50 | $3.17 | 7.73 |
| 2011-07-31 | 25.23 | $2.87 | 8.79 |
| 2011-04-30 | 29.04 | $2.86 | 10.15 |
| 2011-01-31 | 26.50 | $3.00 | 8.83 |
| 2010-10-31 | 24.21 | $2.89 | 8.38 |
| 2010-07-31 | 25.24 | $3.15 | 8.01 |
| 2010-04-30 | 29.64 | $2.79 | 10.62 |
| 2010-01-31 | 28.97 | $2.15 | 13.47 |
| 2009-10-31 | 24.00 | $2.05 | 11.71 |
| 2009-07-31 | 23.68 | $1.78 | 13.30 |
| 2009-04-30 | 21.26 | $2.04 | 10.42 |
| 2009-01-31 | 22.11 | $2.54 | 8.70 |
| 2008-10-31 | 26.46 | $1.96 | 13.50 |
| 2008-07-31 | 34.53 | $2.03 | 17.01 |
| 2008-04-30 | 31.70 | $1.96 | 16.17 |
| 2008-01-31 | 30.20 | $1.94 | 15.57 |
| 2007-10-31 | 30.74 | $2.48 | 12.39 |
| 2007-07-31 | 32.76 | $2.49 | 13.16 |
| 2007-04-30 | 34.14 | $2.41 | 14.17 |
| 2007-01-31 | 34.40 | $2.33 | 14.76 |
| 2006-10-31 | 31.26 | $2.27 | 13.77 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $123.612B | $33.537B |
| Medtronic, Inc. acquired Ireland-based Covidien plc. The acquisition resulted in the formation of a new holding company incorporated in Ireland - Medtronic plc. The company currently generates revenues from four major segments - namely Cardiovascular Portfolio, Medical Surgical Portfolio, Neuroscience Portfolio and Diabetes. The Cardiovascular Portfolio, formerly reported as the Cardiac and Vascular Group, includes the Cardiac Rhythm & Heart Failure, Structural Heart & Aortic and Coronary & Peripheral Vascular divisions. The Medical Surgical Portfolio, formerly reported as the Minimally Invasive Therapies Group, includes the Surgical Innovations and the Respiratory, Gastrointestinal & Renal divisions. Neuroscience consists of Cranial & Spinal Technologies, Specialty The Neuroscience Portfolio, formerly reported as the Restorative Therapies Group, includes the Cranial & Spinal Technologies, Specialty Therapies, and Neuromodulation divisions. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $216.142B | 24.91 |
| EssilorLuxottica (ESLOY) | France | $149.893B | 0.00 |
| Boston Scientific (BSX) | United States | $139.557B | 31.91 |
| Stryker (SYK) | United States | $136.074B | 27.02 |
| Medline (MDLN) | United States | $56.293B | 0.00 |
| Lonza Group Ag (LZAGY) | Switzerland | $49.245B | 0.00 |
| Agilent Technologies (A) | United States | $41.482B | 26.22 |
| GE HealthCare Technologies (GEHC) | United States | $38.615B | 18.47 |
| ResMed (RMD) | United States | $37.167B | 25.72 |
| Koninklijke Philips (PHG) | Netherlands | $28.531B | 18.64 |
| Terumo (TRUMY) | Japan | $21.128B | 23.78 |
| Insulet (PODD) | United States | $19.568B | 60.74 |
| Zimmer Biomet Holdings (ZBH) | United States | $17.507B | 10.92 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $13.553B | 0.00 |
| Baxter (BAX) | United States | $10.101B | 8.15 |
| Sunny Optical Technology (SNPTF) | China | $9.589B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $8.690B | 31.25 |
| Demant (WILYY) | Denmark | $7.372B | 0.00 |
| BillionToOne (BLLN) | United States | $4.433B | 0.00 |
| Lantheus Holdings (LNTH) | United States | $4.366B | 13.30 |
| Envista Holdings (NVST) | United States | $3.820B | 21.92 |
| Haemonetics (HAE) | United States | $3.690B | 16.42 |
| ICU Medical (ICUI) | United States | $3.661B | 23.24 |
| Prestige Consumer Healthcare (PBH) | United States | $3.111B | 14.19 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $3.099B | 0.00 |
| QuidelOrtho (QDEL) | United States | $2.262B | 14.54 |
| Perrigo (PRGO) | Ireland | $2.073B | 5.19 |
| Neogen (NEOG) | United States | $1.999B | 43.76 |
| LeMaitre Vascular (LMAT) | United States | $1.891B | 38.06 |
| AtriCure (ATRC) | United States | $1.810B | 0.00 |
| Curaleaf Holdings (CURLF) | Canada | $1.784B | 0.00 |
| Green Thumb Industries (GTBIF) | United States | $1.742B | 76.36 |
| Phibro Animal Health (PAHC) | United States | $1.640B | 16.38 |
| Lumexa Imaging Holdings (LMRI) | United States | $1.515B | 0.00 |
| AdaptHealth (AHCO) | United States | $1.437B | 20.80 |
| Kestra Medical Technologies (KMTS) | United States | $1.286B | 0.00 |
| BioLife Solutions (BLFS) | United States | $1.151B | 341.43 |
| Capricor Therapeutics (CAPR) | United States | $1.133B | 0.00 |
| Tilray Brands (TLRY) | Canada | $1.054B | 0.00 |
| Maravai LifeSciences Holdings (MRVI) | United States | $1.028B | 0.00 |
| Omeros (OMER) | United States | $0.895B | 0.00 |
| InMode (INMD) | Israel | $0.887B | 10.02 |
| Valneva SE (VALN) | France | $0.864B | 0.00 |
| CeriBell (CBLL) | United States | $0.845B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.564B | 15.30 |
| Cerus (CERS) | United States | $0.484B | 0.00 |
| Verano Holdings (VRNO) | United States | $0.476B | 0.00 |
| Cresco Labs (CRLBF) | United States | $0.472B | 0.00 |
| Brainsway (BWAY) | Israel | $0.467B | 79.45 |
| Canopy Growth (CGC) | Canada | $0.461B | 0.00 |
| SNDL (SNDL) | Canada | $0.434B | 0.00 |
| Evolus (EOLS) | United States | $0.371B | 0.00 |
| Quanterix (QTRX) | United States | $0.334B | 0.00 |
| SEMPERIT AG HLD (SEIGY) | Austria | $0.309B | 0.00 |
| TriSalus Life Sciences (TLSI) | United States | $0.295B | 0.00 |
| Viemed Healthcare (VMD) | United States | $0.276B | 21.97 |
| Sanuwave Health (SNWV) | United States | $0.245B | 0.00 |
| Aurora Cannabis (ACB) | Canada | $0.240B | 141.33 |
| TerrAscend (TSNDF) | Canada | $0.236B | 0.00 |
| High Tide (HITI) | Canada | $0.235B | 0.00 |
| Organigram Global (OGI) | Canada | $0.228B | 0.00 |
| Owens & Minor (OMI) | United States | $0.217B | 2.17 |
| Sanara MedTech (SMTI) | United States | $0.211B | 0.00 |
| Vireo Growth (VREOF) | United States | $0.197B | 0.00 |
| Accendra Health (ACH) | United States | $0.194B | 1.95 |
| Utah Medical Products (UTMD) | United States | $0.188B | 16.54 |
| OraSure Technologies (OSUR) | United States | $0.187B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.158B | 0.00 |
| Apyx Medical (APYX) | United States | $0.148B | 0.00 |
| FitLife Brands (FTLF) | United States | $0.145B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.135B | 0.00 |
| Jushi Holdings (JUSHF) | United States | $0.117B | 0.00 |
| Exagen (XGN) | United States | $0.117B | 0.00 |
| Fonar (FONR) | United States | $0.115B | 16.76 |
| Biote (BTMD) | United States | $0.111B | 4.86 |
| MacroGenics (MGNX) | United States | $0.111B | 0.00 |
| Sharps Technology (STSS) | United States | $0.061B | 0.00 |
| ImmuCell (ICCC) | United States | $0.060B | 25.58 |
| Nephros (NEPH) | United States | $0.047B | 34.00 |
| Cytosorbents (CTSO) | United States | $0.046B | 0.00 |
| Veru (VERU) | United States | $0.039B | 0.00 |
| Jin Medical (ZJYL) | China | $0.038B | 0.00 |
| Rockwell Medical (RMTI) | United States | $0.037B | 0.00 |
| Modular Medical (MODD) | United States | $0.037B | 0.00 |
| United-Guardian (UG) | United States | $0.029B | 14.57 |
| Cellectar Biosciences (CLRB) | United States | $0.017B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.016B | 0.00 |
| Bonk (BNKK) | United States | $0.014B | 0.00 |
| INLIF (INLF) | China | $0.009B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.009B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.007B | 0.00 |
| Flora Growth (FLGC) | United States | $0.007B | 0.00 |
| Zynex (ZYXI) | United States | $0.004B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.003B | 0.00 |
| Agape ATP (ATPC) | $0.003B | 0.00 | |
| Functional Brands (MEHA) | United States | $0.003B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.002B | 0.00 |
| Akanda (AKAN) | Canada | $0.000B | 0.00 |
| InterCure (INCR) | Israel | $0.000B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.000B | 0.00 |